Michael Vazquez

Mr. Michael Vazquez

Cantor Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Current Opinion in Endocrine and Metabolic Research
Verified
Journal Article
Closed access
HYHuan Yang
Huan Yang
MGMichael R Goldstein
Michael R Goldstein
MVMichael Vazquez
Michael Vazquez
JWJonathan P. Williams
Jonathan P. Williams
JMJanet M. Mullington
Janet M. Mullington

3 February 2026 in Pediatric Neurosurgery
Verified
Journal Article
Open access
PMPrabhath Mannam
Prabhath Mannam
MVMichael Vazquez
Michael Vazquez
DMDaniel Mittelman
Daniel Mittelman
EKEthan Knapp
Ethan Knapp
WCWeston Carpenter
Weston Carpenter
DHDavid S. Hersh
David S. Hersh
Introduction: Postoperative recovery following adolescent idiopathic scoliosis (AIS) surgery includes multimodal pain management and physical therapy (PT). Though virtual reality (VR) has been explored as a non-pharmacologic strategy for reducing pain and anxiety during bedside procedures, its impact on postoperative pain and opioid use following AIS correction has not been well characterized. Methods: Adolescent patients undergoing spinal fusion for AIS between March 2024 and June 2025 were eligible for recruitment. Patients completed a 20-min immersive underwater VR scenario prior to each postoperative inpatient PT session. Pain scores (measured on a 10-point Likert scale) before and after PT, opioid usage, number of completed PT sessions, and length of hospitalization were recorded for study subjects and were compared to controls. Results: Ten patients in the VR cohort were compared to 10 controls. There were no differences in sex (p = 0.58), race (p = 0.07), ethnicity (p > 0.99), or average age at surgery (15.1 vs. 15.8 years, p = 0.30). Patients in the VR cohort had a greater average reduction in pain scores associated with postoperative PT compared to controls (−0.72 vs. +0.61, p = 0.02). Patients in the VR and control groups did not differ significantly with regard to total opioid usage in morphine equivalents (55.7 vs. 49.9 mg, p = 0.71), completed PT sessions (3.2 vs. 3.2 sessions, p > 0.99), or length of hospitalization (2.6 vs. 2.4 days, p = 0.53). Side effects of the VR intervention included fatigue (n = 3), nausea (n = 3), headache (n = 2), eye strain (n = 1), and dizziness (n = 1). Conclusion: Our pilot study demonstrated that an immersive VR session prior to each postoperative PT session significantly reduced the change in PT-associated pain scores among patients undergoing spinal fusion for AIS. Future investigations utilizing a randomized controlled design will continue to elucidate the impact of VR on postoperative recovery for patients undergoing AIS correction.

YMYan Ma
Yan Ma
HYHuan Yang
Huan Yang
MVMichael Vazquez
Michael Vazquez
OBOlivia Buraks
Olivia Buraks
MHMonika Haack
Monika Haack
MGMichael R Goldstein
Michael R Goldstein
Despite the growing research base examining the benefits and physiological mechanisms of slow-paced breathing (SPB), mindfulness (M), and their combination (as yogic breathing, SPB + M), no studies have directly compared these in a ”dismantling” framework. To address this gap, we conducted a fully remote three-armed feasibility study with wearable devices and video-based laboratory visits. Eighteen healthy participants (age 18–30 years, 12 female) were randomized to one of three 8-week interventions: slow-paced breathing (SPB, N = 5), mindfulness (M, N = 6), or yogic breathing (SPB + M, N = 7). The participants began a 24-h heart rate recording with a chest-worn device prior to the first virtual laboratory visit, consisting of a 60-min intervention-specific training with guided practice and experimental stress induction using a Stroop test. The participants were then instructed to repeat their assigned intervention practice daily with a guided audio, while concurrently recording their heart rate data and completing a detailed practice log. The feasibility was determined using the rates of overall study completion (100%), daily practice adherence (73%), and the rate of fully analyzable data from virtual laboratory visits (92%). These results demonstrate feasibility for conducting larger trial studies with a similar fully remote framework, enhancing the ecological validity and sample size that could be possible with such research designs.

25 May 2022 in SLEEP
Verified
Journal Article
Open access
PDF file
ASAlicia Stokes
Alicia Stokes
HYHuan Yang
Huan Yang
OBOlivia Buraks
Olivia Buraks
MVMichael Vazquez
Michael Vazquez
SPSarbesh Pandeya
Sarbesh Pandeya
JMJanet Mullington
Janet Mullington
Introduction: Variable sleep/wake patterns have been linked to increased cardiometabolic risk. The current project investigates the effects of using sleep hygiene interventions to stabilize sleep timing in prehypertensive/hypertensive patients. Growing evidence supports the importance of regularizing sleep timing in improving cardiovascular health, and we believe that using sleep hygiene techniques to stabilize sleep may reduce these risks. Methods: As part of a larger study, fifty-three participants (55.5 ± 1.4 years; 51% male) completed sleep diaries during 3 study periods. The first period (S1) was a baseline control, the second period (S2) was a 4-week wait-list control condition, and the third period (S3) was an 8-week randomly assigned intervention that used sleep hygiene approaches and scheduling to stabilize sleep timing or stabilize and lengthen sleep. Currently, we are still blind to condition; however, because both conditions involve sleep stabilization, an analysis using linear mixed models was used to assess change in the variability of total sleep time (SDTST), wake up time (SDWUT), and fall asleep time (SDFAT) across the 3 study periods. Results: There was a significant decrease in SDTST variability (standard deviation) at post-intervention (S3) compared to S2 (p<0.01) and S1 (p<0.01). There was also a significant decrease in SDWUT variability at post-intervention (S3) compared to S2 (p<0.01) and S1 (p<0.01). There was a trend towards a significantly decreased SDFAT at S3 compared to S2 (p=0.057), but there was a significant decrease in SDFAT variability during S3 compared to S1 (p<0.01). Conclusion: These data suggest that we were able to utilize sleep hygiene interventions to decrease the variability in total sleep time, wake-up time and fall asleep time. When we unblind we will report on if we were able to increase and lengthen the sleep period for those in the sleep extension condition. Support (If Any): NIH (R01HL125379 to Dr. Janet Mullington), Harvard Catalyst, Harvard Clinical and Translational Science Center (UL1TR001102)

1 May 2021 in SLEEP
Verified
Journal Article
Closed access
PDF file
HYHuan Yang
Huan Yang
MVMichael Vazquez
Michael Vazquez
MHMonika Haack
Monika Haack
JMJanet Mullington
Janet Mullington
Introduction Insufficient sleep is associated with an increased risk of hypertension. It is well established that long-term BP regulation is modulated by the renin-angiotensin-aldosterone system (RAAS) and chronic kidney disease is a strong independent risk factor for development of cardiovascular disease. This study investigated the biomarkers of RAAS and renal function during repetitive exposures to controlled, experimental sleep restriction (SR). We hypothesized an upregulation of RAAS and increased markers of impaired renal function. Methods Twenty-one healthy participants (11 women, average age 31±2 years) completed the 22-day in-hospital SR protocol: permitted 4h of sleep/night from 0300-0700 for 3 nights followed by a recovery sleep, repeated 4 times. Blood samples were collected and plasma renin activity (PRA) was assessed in the morning (7:05am) and in the evening before bedtime (22:45pm) at baseline, experimental days (3rd day of each of the 4 blocks), and recovery. Urinary albumin to creatinine ratio (ACR) was measured from 24-h urinary collection at baseline, first and fourth SR blocks. Estimated glomerulus filtration rate (eGFR) was calculated based on the serum cystatin C levels at baseline and last block of SR. Results Percent change of evening PRA significantly increased during 4 blocks of SR and recovery (SR effect p=0.039), but not morning PRA (SR effect p=0.34). Specifically, evening PRA increased up to 98.4% in the first (p<0.01), 61.3% in the second (p=0.04) SR blocks, and 57.5% (p=0.05) in recovery. Urinary ACR showed no significant changes during first or fourth SR blocks (SR effect p=0.28). In addition, eGFR did not change in the fourth SR block compared to BL (paired t-test, p=0.27). Conclusion We did not see increased markers of impaired renal function (ACR or eGFR). Rather, short-term repetitive exposures to SR significantly increased percent change of PRA measured before bedtime, and evening PRA did not return to BL level during recovery. Our results suggested that sleep deficiency may contribute to hypertension through upregulation of RAAS during wake time. Support (if any) SRSF (CDA to Huan Yang), NIH (R01HL106782 to Dr. Janet Mullington), Harvard Catalyst, Harvard Clinical and Translational Science Center (UL1TR001102).

1 September 2021 in Hypertension
Verified
Journal Article
Closed access
HYHuan Yang
Huan Yang
MVMichael Vazquez
Michael Vazquez
AEAnnika Eske
Annika Eske
EPEmily Peachthong
Emily Peachthong
JMJanet Mullington
Janet Mullington
Introduction: Recent epidemiologic studies report that shorter sleep duration is associated with a rapid decline in renal function. This project investigated the effects of 8 weeks of sleep hygiene interventions on the renin-angiotensin-aldosterone system (RAAS) regulation and markers of renal function. Accumulating evidence suggests that sleep plays an important role in blood pressure (BP) regulation. While BP is influenced by renal function, it is not known if improving sleep hygiene may support regulation of the RAAS. Methods: Fifty participants (59.8 ± 1.5 years; 31 women) completed 3 overnight in-hospital stays: baseline (S1), pre-intervention (S2) following a 4-week wait-list evaluation phase from S1 and post-intervention (S3). During S2, participants with elevated BP (BP>120/80 to <160/100) were randomly assigned to two sleep hygiene conditions where in both conditions, the sleep period was stabilized, but in one it was also lengthened. As the study is still ongoing, we remain blind to which condition participants were randomized to. Morning and evening plasma renin activity (PRA), urinary albumin, creatinine, and serum cystatin C levels were measured from all three stays. Albumin-to-creatinine ratio (ACR) and estimated glomerulus filtration rate (eGFR) were calculated. Results: There was a significant decrease of night PRA at post-intervention (S3) compared to S2 (p<0.05) and S1 (p<0.05). However, morning PRA did not show any changes throughout the stays (p=0.3). The urinary ACR obtained from evening urine samples did not show significant changes (p=0.66). In addition, serum cystatin C levels measured from evening blood draws and the eGFR did not show significant changes (p=0.21 and p=0.18, respectively). Conclusion: The sleep hygiene approach to improving sleep was associated with blunted PRA levels in the evening. When unblinded we will report on whether increasing the sleep period was more effective than stabilizing circadian placement of sleep, alone.